https://www.selleckchem.com/products/kpt-9274.html
BACKGROUND/AIM We compared patients with advanced gastric cancer [Union for International Cancer Control (UICC) III] versus patients with stage UICC IV and peritoneal carcinomatosis treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) versus patients with stage UICC IV treated without HIPEC to ascertain if CRS and HIPEC improve overall survival (OS). PATIENTS AND METHODS We retrospectively analysed thirty-seven advanced gastric cancer patients who had been treated at our department from 2012 to
Like
Comment
Share
